This month's main topic: Special Edition: COVID-19
ISMP Medication Safety Alert!®
Nurse AdviseERR
Providing a valuable resource specifically for nurses to reduce medication error risk in any healthcare setting
*Nurse AdviseERR® is currently offered FREE thanks to support from Fresenius Kabi and Ivenix.
The ISMP Medication Safety Alert!® Nurse AdviseERR is a digital newsletter, published monthly. It is specifically designed to meet the unique medication safety and education needs of nurses who transcribe orders, administer medications, and monitor the effect of medications on patients.
Nurses in the following settings read this newsletter:
- Acute care hospitals
- Behavioral health facilities
- Community health clinics
- Surgical centers
- Birthing centers
- Faculty at academic settings to share with student nurses
*Nurse AdviseERR® is currently offered free to nurses thanks to support from Fresenius Kabi and Ivenix.
Subscription Options
Online access to twelve (12) issues per year. You will receive a reminder notice via email to renew your annual subscription before your subscription expires. Your subscription will not automatically renew.
Single issues are available for purchase.
Academic-based subscription: contact ISMP for pricing
Pharmaceutical Industry (and other healthcare related companies): contact ISMP for pricing
Personal Subscription
Subscription Information
-
$0.00 per year
-
Online access for one (1) user
-
Contact ISMP for redistribution permissions
Browse Issues
Nurse AdviseERR
Volume 18, Issue 2
This month's main topic: Errors Associated with Oxytocin Use: A Multi-Organization Analysis by ISMP and ISMP Canada
Nurse AdviseERR
Volume 18, Issue 1
This month's main topic: A Lot Happens When You Report a Hazard or Error to ISMP – There’s No “Black Hole” Here!
Nurse AdviseERR
Volume 17, Issue 12
This month's main topic: What’s in a Name? Survey Finds Wide Variety of Error-Prone Newborn Naming Conventions in Use Today
Nurse AdviseERR
Volume 17, Issue 11
This month's main topic: Speaking Up about Patient Safety Requires an Observant Questioner and a High Index of Suspicion
Nurse AdviseERR
Volume 17, Issue 10
This month's main topic: Published Review of Independent Double Checks Shouldn’t Dissuade Providers from Using Them Judiciously
Nurse AdviseERR
Volume 17, Issue 9
This month's main topic: IV Push Gap Analysis Tool (GAT) Helps Uncover National Priorities for Safe Injection Practices
Nurse AdviseERR
Volume 17, Issue 8
This month's main topic: Call to Action: Longstanding Strategies to Prevent Accidental Daily Methotrexate Dosing Must be Implemented
Nurse AdviseERR
Volume 17, Issue 7
This month's main topic: Common Missteps with Medication Safety: Rolling a Single Dice, Ineffective Strategies, and Unexecuted Action Plans
Nurse AdviseERR
Volume 17, Issue 6
This month's main topic: Independent Double Checks: Worth the Effort if Used Judiciously and Properly
Nurse AdviseERR
Volume 17, Issue 5
This month's main topic: Newborn Naming Conventions and Wrong-Patient Errors
Nurse AdviseERR
Volume 17, Issue 4
This month's main topic: RITUXAN HYCELA and HERCEPTIN HYLECTA Must Be Given Subcutaneously, Despite Large Dose Volumes
Nurse AdviseERR
Volume 17, Issue 3
This month's main topic: Mix-ups Between Epidural Analgesia and IV Antibiotics in Labor and Delivery Units Continue to Cause Harm
Nurse AdviseERR
Volume 17, Issue 2
This month's main topic: Another Round of the Blame Game: A paralyzing Criminal Indictment that Recklessly “Overrides” Just Culture
Nurse AdviseERR
Volume 17, Issue 1
This month's main topic: Errors Due to the Presentation of Results on Accu-Chek Inform II and Possibly Other Glucometers
Nurse AdviseERR
Volume 16, Issue 12
This month's main topic: Part II: Survey Results Suggest Action Is Needed to Improve Safety with Adult IV Push Medications
Nurse AdviseERR
Volume 16, Issue 11
This month's main topic: Part I: Survey Results Show Unsafe Practices Persist with IV Push Medications
Nurse AdviseERR
Volume 16, Issue 10
This month's main topic: Ongoing Risk: Misconnections of Tracheostomy Pilot Balloon Ports with IV Infusions Can Result in Fatal Outcomes